Levamisole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg & 150 mg
Reference Brands: Generic formulations
Category:
Anthelmintic
Levamisole enhances immune response by stimulating T-cell activity and modulating immune function. It also has anthelmintic properties, targeting parasitic worms. Benefits include effective treatment of intestinal parasites, immune support in certain diseases, and potential cancer therapy adjuncts. It supports parasite eradication and immune modulation worldwide.
Levamisole tablets is available in Tablets
and strengths such as 50 mg & 150 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Levamisole tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Levamisole tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Levamisole tablets are approved primarily in Europe for parasitic infections and immune modulation, with limited regulatory approval in the US. Regulatory dossiers must include clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews quality and safety data, while the EU’s EMA oversees regional safety and quality compliance. For guidance on dossier preparation, regulatory pathways, and market entry, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and global availability, ensuring effective treatment of parasitic infections and immune-related conditions worldwide, with a focus on safety and efficacy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing